Validation of the Blood Test MACK-3 for the Noninvasive Diagnosis of Fibrotic Nonalcoholic Steatohepatitis: An International Study With 1924 PatientsCLINICAL GASTROENTEROLOGY AND HEPATOLOGYIF122023-11-018PRE
Clinical Outcome After Left Ventricular Thrombus Resolution: Who Needs Long-Term or Lifetime Use of Anticoagulants?左心室血栓消退后的临床结果: 谁需要长期或终生使用抗凝剂？JOURNAL OF THE AMERICAN HEART ASSOCIATIONIF5.32023-04-187OAAI
J-shaped relationship between serum zinc levels and the severity of hepatic necro-inflammation in patients with MAFLDNUTRITION METABOLISM AND CARDIOVASCULAR DISEASESIF3.72022-05-019OAAI
Protective association of Klotho rs495392 gene polymorphism against hepatic steatosis in non-alcoholic fatty liver disease patientsCLINICAL AND MOLECULAR HEPATOLOGYIF16.92022-04-016OAAI
Short-Term Postoperative Use of Rivaroxaban to Prevent Radial Artery Occlusion After Transradial Coronary Procedure: The RESTORE Randomized TrialCIRCULATION-CARDIOVASCULAR INTERVENTIONSIF7.42022-04-0117OA
A novel radiomics signature based on T2-weighted imaging accurately predicts hepatic inflammation in individuals with biopsy-proven nonalcoholic fatty liver disease: a derivation and independent validation studyHEPATOBILIARY SURGERY AND NUTRITIONIF7.82022-04-0113OA
Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an inter-national registry studyMETABOLISM-CLINICAL AND EXPERIMENTALIF11.92022-01-0147OA
The uprising of metabolic dysfunction-associated fatty liver disease (MAFLD) in acute-on-chronic liver failure (ACLF)HEPATOBILIARY SURGERY AND NUTRITIONIF7.82021-12-017OA
acNASH index to diagnose nonalcoholic steatohepatitis: a prospective derivation and global validation studyECLINICALMEDICINEIF102021-11-0122OAAI
PNPLA3 rs738409 C> G Variant Influences the Association Between Visceral Fat and Significant Fibrosis in Biopsy-proven Nonalcoholic Fatty Liver Diseaseclinical and translational gastroenterologyIF4.22021-10-225OAAI
LC-MS-based lipidomic analysis in distinguishing patients with nonalcoholic steatohepatitis from nonalcoholic fatty liverHEPATOBILIARY & PANCREATIC DISEASES INTERNATIONALIF4.42021-10-0119PREAI
Letter: Hepatitis B and MAFLD - a consilience of risk factors for hepatocellular carcinomaALIMENTARY PHARMACOLOGY & THERAPEUTICSIF6.72021-08-112OAAI
Interaction of SAMM50-rs738491, PARVB-rs5764455 and PNPLA3-rs738409 Increases Susceptibility to Nonalcoholic Steatohepatitisclinical and translational gastroenterologyIF4.22021-07-298OAAI
Sex influences the association between appendicular skeletal muscle mass to visceral fat area ratio and non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver diseaseBRITISH JOURNAL OF NUTRITIONIF32021-06-2810OAAI
TA allele of rs2070673 in the CYP2E1 gene is associated with lobular inflammation and nonalcoholic steatohepatitis in patients with biopsy-proven nonalcoholic fatty liver diseaseJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGYIF3.42021-06-066PREAI
The HSD17B13 rs72613567 variant is associated with lower levels of albuminuria in patients with biopsy-proven nonalcoholic fatty liver diseaseNUTRITION METABOLISM AND CARDIOVASCULAR DISEASESIF3.72021-06-0111OAAI
Machine learning algorithm outperforms fibrosis markers in predicting significant fibrosis in biopsy-confirmed NAFLDJOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCESIF2.82021-05-1229OAAI
Clinical characteristics and outcomes in patients with echocardiographic left ventricular spontaneous echo contrastINTERNATIONAL JOURNAL OF CARDIOLOGYIF3.22021-05-012PREAI
Specific epigenetic age acceleration patterns among four molecular subtypes of gastric cancer and their prognostic valueEPIGENOMICSIF2.62021-04-204PRE
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向